Rhythm and conduction disorders in children with hypertrophic cardiomyopathy

Authors:

Abstract
Rhythm and conduction disorders remain key determinants of prognosis in hypertrophic cardiomyopathy. Objective. To assess the nature, frequency, and clinical-prognostic significance of cardiac rhythm and conduction disorders in children with hypertrophic cardiomyopathy. Materials and Methods . This retrospective-prospective study included 200 children with confirmed primary hypertrophic cardiomyopathy (median age 14.34 years; 2/3 male). Median follow-up was 5.74 years. Life-threatening arrhythmias were defined as sudden cardiac death, aborted sudden cardiac death, or appropriate implantable cardioverter-defibrillator therapy. Results. Rhythm and conduction disorders were detected in 77 % of children. Ventricular extrasystole ≥ 10/24h was observed in 25.5 %, and non-sustained ventricular tachycardia in 20.5 %. Life-threatening arrhythmias occurred in 27 children (13.5 %): sudden cardiac death (n = 6), aborted sudden cardiac death (n = 11), and appropriate implantable cardioverter-defibrillator shocks for primary prevention (n = 10). Ventricular extrasystole 10–500/24h (OR 4.93; p = 0.00002) and ventricular extrasystole ≥ 500/24h (OR 6.84; p = 0.015) were associated with non-sustained ventricular tachycardia. Extreme myocardial hypertrophy increased the odds of non-sustained ventricular tachycardia 2.3-fold (p = 0.018). Sick sinus syndrome was diagnosed in 10.5 % of children and was a strong predictor of life-threatening arrhythmias (OR 5.18; pConclusion . Hypertrophic cardiomyopathy is characterized by a high prevalence of rhythm and conduction disorders. Even moderate ventricular extrasystole is associated with non-sustained ventricular tachycardia, justifying routine Holter monitoring in all children with hypertrophic cardiomyopathy. Sick sinus syndrome is associated with a fivefold increased risk of life-threatening arrhythmias and should be incorporated into sudden cardiac death risk stratification algorithms. Such patients may warrant a lower 5-year sudden cardiac death risk threshold for dual-chamber cardioverter-defibrillator implantation.

This publication has 35 references indexed in Scilit: